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Cdc25any animal embryos, rapid synchronous cleavage divisions give way to longer,
asynchronous cell cycles at the midblastula transition (MBT). The cell cycle changes at the MBT, including the
addition of gap phases and checkpoint controls, are accompanied by activation of the zygotic genome and the
onset of cell motility. Whereas the biochemical changes accompanying the MBT in the vertebrate embryo
have been extensively documented, the cellular events are not well understood. We show that cell cycle
remodeling during the zebraﬁsh MBT includes the transcription-independent acquisition of a G2 phase that
is essential for preventing entry into mitosis before S-phase completion in cycles 11–13. We provide evidence
from high-resolution imaging that inhibition of Cdc25a and Cdk1 activity, but not Cdk2 activity, is essential
for cell cycle lengthening and asynchrony between cycles 9 and 12. We demonstrate that lengthening is not
required for initiation of zygotic transcription. Our results are consistent with ﬁndings from Drosophila and
Xenopus that indicate the central importance of G2 addition in checkpoint establishment, and point to similar
mechanisms governing the MBT in diverse species.
© 2008 Elsevier Inc. All rights reserved.Introduction
The developmental program of many metazoan embryos is
initiated with a series of rapid and synchronous reductive divisions
characterized by repeating M and S phases with no intervening gap
phases (Edgar et al., 1986; Kane and Kimmel, 1993; Newport and
Kirschner, 1982a). After several such divisions, embryos undergo the
midblastula transition (MBT), in which cell cycles are elongated and
desynchronized, and zygotic transcription and cell movement
commence (Newport and Kirschner, 1982b). The cell cycle remodeling
events include lengthening of S-phase as maternally provided
replication factors become limiting, and the establishment of
checkpoint controls to ensure complete DNA replication as S-phase
lengthens. Extensive experimental evidence has demonstrated that
the timing of the MBT, while organism-speciﬁc, is a function of the
nucleocytoplasmic ratio. Most of these events have been shown to be
independent of zygotic transcription in Drosophila and Xenopus
embryos, where the MBT has been best characterized (Edgar et al.,
1986; Newport and Kirschner, 1982b).
Initial cell cycle lengthening in Drosophila embryos is thought to
result from limitation of cyclin proteins, translated from maternally
provided mRNA, in the syncitial blastoderm. Cellularization of the
blastoderm is concomitant with the introduction of a very long G2,l rights reserved.(Edgar and O'Farrell, 1989; Foe and Alberts, 1983), resulting from
destruction of maternally provided Cdc25 phosphatase string and
twinemRNAs (Edgar and Datar, 1996), and function of theWee mitotic
kinase inhibitor (Stumpff et al., 2004). Together, these events result in
hyperphosphorylation and inhibition of Cdk1 and introduction of a
G2/M block. Loss of function alleles of string cause a complete arrest in
G2 of cycle 14 (Edgar and O'Farrell, 1990), whereas inhibition of string
or twine mRNA degradation (Edgar and Datar, 1996) and reduction in
maternally contributed Wee activity (Stumpff et al., 2004) abolish cell
cycle lengthening in the cycles before interphase-14. Subsequent
entry into mitosis requires zygotic string transcription in precisely
deﬁned spatiotemporal domains (Edgar and O'Farrell, 1990).
Similarly, destruction ofmaternal Cdc25Aoccurs atMBT in Xenopus
embryos, though it is not clear whether this is necessary or sufﬁcient
for cell cycle lengthening, as overexpression of wild type Cdc25A does
not disrupt embryonic development (Shimuta et al., 2002). However,
other events, such as the Chk1-dependent inactivation of Cdc25A and
the stabilization of Wee1, contribute to an accumulation of phos-
phoinhibited Cdk1 and Cdk2. More recently, it was demonstrated that
a Chk1-dependent modiﬁcation of Cdc25 activity that occurs at the
MBT is required for cell viability at later stages (Uto et al., 2004).
Despite the prominence of the zebraﬁsh as a model system for
investigating genetic and molecular mechanisms directing embryonic
development, surprisingly little is known about the molecular events
at the zebraﬁsh MBT. Work by Kane and Kimmel showed that the MBT
begins at cycle 10 and is characterized by cell cycle lengthening and
asynchrony (Kane and Kimmel, 1993). As in Xenopus and Drosophila,
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ratio and coincident with the onset of zygotic transcription (Dekens et
al., 2003; Kane and Kimmel, 1993). However, the molecular mechan-
isms that bring about lengthening, the nature of the cell cycle
remodeling, and the role of zygotic transcription in cell cycle
lengthening have been less clear. Zamir et al. used ﬂow cytometry to
demonstrate the addition of a transcription-dependent G1phase at the
MBT, and have suggested that this G1 phase, as well as the
transcription-independent S-phase elongation, account for cell cycle
lengthening and asynchrony (Zamir et al., 1997). These results raised
the possibility that important differences exist in themechanisms that
bring about cell cycle remodeling in zebraﬁsh, Xenopus andDrosophila.
Here, we have used high resolution imaging in live embryos to
directly measure cell cycle lengths, and we provide evidence that
initial cell cycle lengthening and desynchronization includes the
acquisition of a G2 phase by a transcription-independent mechanism.
We demonstrate that phosphoinhibition of Cdk1, but not Cdk2, is
necessary and sufﬁcient for cell cycle lengthening between cycles 10
and 12, and is an essential component of asynchrony and G2 addition
at the zebraﬁsh MBT. We show that Cdk1 inactivation is essential for
completion of DNA replication in cycle 12 and 13. Finally, we
demonstrate that zygotic transcription is initiated even when G2
addition and checkpoint bypass are experimentally induced to
suppress cell cycle lengthening.
Materials and methods
Fish husbandry
Adult zebraﬁsh (Danio rerio) were maintained at 28 °C as described
in Westerﬁeld (2000). Embryos were collected from natural mating
and staged according to Kimmel et al. (1995). All experiments were
carried out in the DZ strain, which were originally acquired from
Scientiﬁc Hatcheries (CA) and bred in the laboratory for eight
generations. All embryo incubations were done at 28 °C, with the
exception of the time lapse measurements. These were performed at
22–25 °C. Embryos were staged by blastomere number (pre-MBT) and
morphology (post-MBT).
Transcription-block experiments
For transcription-blocking experiments, wild type embryos were
injected at the one-cell stage with 2 nL 0.2 mg/mL α-amanitin (Fluka
Biochemika), incubated at 28 °C to the desired stage, and ﬁxed in 4%
paraformaldehyde. Control embryos were prepared by injecting 2 nL
ddH2O. Nuclear stains were performed with 10 μg/mL Hoechst 33342
(Invitrogen Molecular Probes). Immunoﬂuorescence was performed
as described below.
BrdU mitotic pileup experiments
For the experiments in Figs. S1, Fig. 1 and Fig. 6, the general
procedure for BrdU/nocodazole pulse labeling was as follows:
embryos were injected in the yolk with 5 nL of 10 mM BrdU+1 unit/
mL nocodazole. Embryos were incubated at 28 °C in E3+1 unit/mL
nocodazole for ﬁfteen, thirty, and 45 min, and were ﬁxed in 4%
paraformaldehyde. BrdU detection was performed by permeabilizing
embryos in PBS+1% Triton X-100 for 4 h at room temperature
followed by incubation in 3 M HCl for 20 min. Acid-denatured
embryos were washed 4×15 min in PBS+0.5% Triton X-100 and then
incubated in blocking solution for 1 h followed by overnight
incubation at 4 °C in anti-BrdU antibody (Sigma) (1:100). Embryos
were thenwashed six times for 15 min each in PBT, incubated in goat-
anti-mouse Alexaﬂuor488-labeled secondary antibody (Invitrogen,
1:500) for 2 h at room temperature and then washed extensively in
PBT. These embryos were incubated overnight at 4 °C in a 1:1000propidium-iodide or TO-PRO3® iodide solution (Invitrogen) to
counter stain nuclei and mounted in Vectashield (Vector Labora-
tories). In all pileup experiments, all visibly condensed nuclei were
considered mitotic, and all nuclei with detectable anti-BrdU ﬂuores-
cence were considered BrdU-labeled.
To determine the minimal time to allow for efﬁcient uptake of
BrdU and nocodazole, we ﬁrst ran a series of control experiments with
cleavage-stage embryos. Embryos at 64-cell stage were injected and
processed as above. Fixed and stained embryos were deyolked and
imaged on a Zeiss Axiovert 200 M at 20×. During cleavage stages,
blastomeres progress through the cell cycle relatively synchronously,
so an entire embryo has uniform distribution of interphase or mitotic
ﬁgures, or of BrdU-labeled or unlabeled ﬁgures. The data for Fig. S1
were acquired by counting the number of embryos in which all cells
fell into a particular category.
After 5- or 10-minute pulses, we observed several embryos with
inconsistent BrdU labeling, suggesting non-uniform uptake. We also
saw several embryos with abnormal anaphase or telophase ﬁgures,
suggesting partial escape from the nocodazole arrest. Neither of these
classes of embryos was present following a 15-minute incubation. This
suggests that the dead time of this experiment (the time for efﬁcient
uptake of BrdU and nocodazole) is on the order of 10 min. We
therefore set a 15-minute BrdU/nocodazole pulse as the minimum
time point for this experiment.
We then conﬁrmed that a 15-minute pulse is sufﬁcient to allow
accumulation of BrdU-labeled ﬁgures in cell cycles lacking a G2 phase
(Fig. S1), that the proportion of BrdU-labeled mitotic cells increases,
and the proportion of BrdU-labeled interphase ﬁgures decreases, as
pulse time increases. We also saw that in cleavage stage embryos, the
proportion of embryos with unlabeled mitotic ﬁgures does not change
with increased pulse time and therefore reﬂects a baseline population
of cells that have entered mitosis at the time of injection that become
trapped by nocodazole during the incubation.
For the post-MBT analysis, embryos at sphere stage were injected
and incubated as described above. At sphere stage, cell cycles within a
single embryo are highly asynchronous, so in this case we counted
individual cells from a number of embryos in small ﬁelds of 20–50
cells. The use of small ﬁelds reduces the potential for effects of non-
uniform exposure, as exposure conditions within a spatially contig-
uous ﬁeld are likely to have been identical. Fields of cells were
acquired using a Zeiss LSM-510 confocal microscope equipped with a
63× objective lens. To prevent channel bleed-through between the TO-
PRO3 and Alexaﬂuor-488 channels, these ﬁelds were acquired using
the META spectral analyzer. These data were analyzed in ImageJ and
nuclei were manually enumerated and classiﬁed (BrdU-positive
interphase, BrdU-negative interphase, BrdU-positive mitosis and
BrdU-negative mitosis) using the cell counter function. All condensed
nuclei were counted as M-phase.
The experiments in Fig. 6 were initiated during cycle 12 for reasons
explained in the Results section, and performed as described for
sphere stage embryos.
Time-lapse analysis
To measure cell cycle lengths, we conducted time-lapse confocal
microscopy on embryos injected with 0.5 nL 2 mg/mL Alexaﬂuor-488
labeled Histone proteins (Invitrogen) at the one-cell stage. Injection of
these proteins did not have a detectable effect on cell behavior during
either early or late development, and injected embryos were
indistinguishable from uninjected sibling embryos at 24, 48 and
72 hpf (Supplemental Fig. S2). Embryos were selected for correct
cleavage morphology and uniform nuclear labeling at the 8-cell stage.
To test the effect of overexpressing cell cycle regulators on early
cell cycle dynamics, 1 nL of solution containing mRNA encoding
various cell cycle regulatory genes was injected into single blasto-
meres of labeled embryos at the 8-cell stage. Under these conditions,
Fig. 1.Mitotic pileup assay in post-MBT embryos. (A–F) Wild type embryos injected with BrdU and nocodazole at sphere stage, and incubated for 15 (A–C) or 30 (D–F) minutes before
ﬁxation and BrdU detection. Propidium iodide stained nuclei are labeled green, with BrdU positive nuclei labeled red. White arrowheads indicate BrdU-negative interphase nuclei,
black and white arrowheads indicate BrdU-positive nuclei, white arrows indicate BrdU-negative mitotic ﬁgures, and black and white arrows indicate BrdU-positive mitotic ﬁgures.
(G) Quantitation of BrdU-labeled mitotic pileup experiments. Filled bars represent a 15-minute BrdU pulse, hashed bars represent a 30-minute pulse, and open bars represent a 45-
minute pulse. For each data point, nN15 ﬁelds and N300 cells.
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1/8th of the cell lineages in the embryo, deriving from the single
injected blastomere at the 8-cell stage, carry the mRNA, while the
other lineages are uninjected and can be treated as wild-type. The
presence of injected and uninjected lineages in the same embryo
allowed for each experiment to be internally controlled. This is
important because the rate of cleavage in pre-MBT embryos is highly
temperature-dependent.
Embryos were manually dechorionated and placed in an imaging
chamber consisting of an inverted 3 cm Petri dish with a cover slip
window. Within this chamber embryos were placed in depressions
made in 1% agarose and then overlaid with 0.25–0.35% low gelling
temperature agarose (Sigma). Embryos were then imaged on a Zeiss
LSM510 Meta/NLO system (Carl Zeiss, Thornwood. NY, USA) running
Zeiss AIM version 3.5. Time-lapse movies were recorded using a 20X
objective lens with a pinhole diameter corresponding to ﬁve airy
units. A 15-image three-dimensional stack covering some 150 μm at
an approximately 8–10 μm inter-plane distance was acquired every
2 min for at least 4 h. To differentiate injected from uninjectedlineages, an initial and ﬁnal z-stack was obtained visualizing the
rhodamine-dextran signal. This data was used to assign nuclear
lineages to either injected or uninjected clones and no further
rhodamine-dextran labeling data was collected to minimize photo-
toxicity and increase acquisition speed.
The ﬁnal movies were imported into the ImageJ program (Wayne
Rasband, NIH, USA) (Abramoff et al., 2004) and converted into four-
dimensional images using the image5D plug-in (Joachim Walter,
Ludwig-Maximilians-Universität, Munich). The MtrackJ plug-in (Erik
Meijering, Erasmus MC, Rotterdam) was used to track individual cell
lineages and the division times (marked by the ﬁrst appearance of
telophase and chromatid separation) were recorded. Data collection
was performed in Open Ofﬁce and statistical analysis and graphing
was performed in Graphpad prism.
From these time-lapse movies, cell cycle time information was
obtained for eight injected and eight uninjected lineages from the 32-
cell stage until two divisions after the 1 K-cell stage (1 K+2, or M13).
Data collected from these movies are analyzed in twoways. The ﬁrst is
the absolute length of each cell cycle from telophase to telophase,
134 D.E. Dalle Nogare et al. / Developmental Biology 326 (2009) 131–142plotted as a bar graph. The second method is the time at which each
mitotic division occurs, plotted as a line graph. In these movies, we
document rapid, synchronous pre-MBT cycles, followed by cell cycle
lengthening and desynchronization, as demonstrated by the increase
in the standard deviation of themeasured cell cycle lengths, beginning
at cycle 10.
In our hands pre-MBT cycles ranged between 18 and 25 min in
length and were statistically indistinguishable from each other in
terms of total length. Slight lengthening was observed at cycle 10
becoming more signiﬁcant during cycle 11 and 12. Typically, M13 was
not documented during the length of these movies. For reference,
cycle 7 in the bar graph refers to the 64 cell-stage, that is, the time
between the ﬁrst two points on the line graph (between the 32–64
and 64–128 divisions).
Cdc25 and Cdk1 overexpression
cdc25a, cdc25d, cdk1, cdk2 and mutant forms were cloned by PCR
ampliﬁcation from a mid-gastrula cDNA library (Sagerstrom et al.,
2001) into the XbaI and XhoI sites of vectors pCS2+ or pCS2+MT (for
N-terminal Myc-tagged expression), linearized by digestionwith Not1
and transcribed using SP6 RNA polymerase. For each construct,
expression was conﬁrmed by anti-Myc immunoﬂuorescence in
asymmetrically-injected embryos or Western blots prepared from
explanted animal caps (Grinblat et al., 1999). Untagged variants were
also expressed as a control for activity loss by Myc-tagging. We found
that the N-terminal Myc tag appears to interfere with Cdk1 protein
activity, as judged by the failure of 6MT-Cdk1AF to alter cell cycle
kinetics when compared to untagged Cdk1AF. All other injected
mRNAs showed similar results with tagged and untagged variants.
Immunoﬂuorescence
Immunoﬂuorescence was carried out as described (Dalle Nogare et
al., 2007). The following antibodies and antibody dilutions were used.
Anti-myc clone 9E10 (Upstate Biotechnology, 1:500) Anti-phospho-
RNA Polymerase II clone H5 (Cell Signalling Technologies, 1:100).
Nuclei were visualized by staining with Hoechst 33342 or TO-PRO®.
Antibodies were used in conjunction with AlexaFluor ﬂuorescent
secondary antibodies.
Results
A G2 is introduced shortly after the MBT
A previous study using ﬂow cytometry on dissociated zebraﬁsh
embryonic cells demonstrated that S-phase is lengthened, and a
transcription dependent G1 phase is introduced at the MBT (Zamir et
al., 1997). However, as this methodology does not distinguish between
a 4N G2 population and a 4NM population, the previous study did not
address the timing or mechanism of addition of a G2 phase. Given the
importance of G2 checkpoints monitoring DNA damage and DNA
replication completion, we decided to directly inquire how and when
G2 is added to zebraﬁsh embryo cell cycle.
To determine whether a G2 phase is introduced during the MBT,
we performed mitotic trapping experiments in conjunctionwith BrdU
labeling to infer the amount of time that cells need to transition from
S-phase to mitosis. In these experiments, embryos are incubated with
BrdU in the presence of nocodazole, a microtubule polymerization
inhibitor that arrests cells in mitosis (Jordan et al., 1992). Cells in S-
phase will incorporate BrdU during the incubation. Cells that enter
mitosis and proceed tometaphase any time during the incubationwill
be trapped by nocodazole. The rate of accumulation of BrdU-labeled
mitotic ﬁgures therefore, will be a function of the time needed to pass
from S-phase to mitosis. Mitotic cells that are not labeled with BrdU
may be either cells that were in G2 at the beginning of the pulse orcells in early mitosis during the time of incubation. BrdU-labeled
interphase cells are those that are in S-phase at any time during the
incubation, and may also be in a gap phase during part of the
incubation, but have not entered into mitosis.
We determined that 15 minutes is the minimal time for BrdU-
nocodazole incubations to ensure complete penetration of both agents
throughout the embryo (seeMaterials andmethods). In cleavage stage
embryos, before the MBT, the majority of mitotic cells are BrdU-
labeled after a 15-minute pulse, indicating that 15minutes is sufﬁcient
time for most cells to progress from S-phase to mitosis prior to the
MBT (Fig. S1).
We then performed the experiment in sphere stage embryos, after
the MBT, to retrospectively assess whether a G2 phase has been added
to the cell cycle during MBT. At the sphere stage, cell cycles are
asynchronous and most cells are in cycles 13 and 14 (Kane and
Kimmel, 1993). We observed a mixture of BrdU-labeled and unlabeled
nuclei, and of mitotic and interphase nuclear ﬁgures in each embryo
(Figs. 1A–G). We saw that most cells are BrdU-labeled interphase cells,
in agreement with the observed extended S-phase in post-MBT cells
(Zamir et al., 1997). We observed no BrdU-labeled mitotic ﬁgures after
a 15-minute pulse (Figs.1A–C, G), indicating thatmore than 15min are
required to pass from S-phase to mitosis after the MBT. We also
observed a small population of interphase cells that was not BrdU-
labeled, suggesting the presence of a gap phase, and a larger
population of mitotic cells that was not BrdU-labeled (Figs. 1A–C, G),
indicating that cells had completed S-phase before the incubation
period and had begun progression toward mitosis during the
incubation period.
When the incubation time was increased to 30 min, the
distribution changed, with a decrease in the proportion of BrdU-
labeled interphase ﬁgures as well as unlabeled interphase ﬁgures
(Figs. 1D–G), an increase in the proportion of unlabeled mitotic
ﬁgures, and the ﬁrst appearance of BrdU-labeled mitotic ﬁgures. The
increase in unlabeled mitotic ﬁgures, not seenwith similar incubation
periods with cleavage stage embryos (Fig. S1), and the concomitant
decrease in unlabeled interphase ﬁgures, is consistent with the
presence of a group of cells that pass from G2 and become trapped in
mitosis. The appearance of BrdU-labeled mitotic ﬁgures is consistent
with cells that pass from S-phase, through G2 and become trapped in
mitosis. When the incubation time was increased to 45 min, more
BrdU-labeledmitotic ﬁgures were observed, but therewere no further
decreases in the number of unlabeled interphase ﬁgures or in the
number of unlabeledmitotic ﬁgures (Fig. 1G), suggesting that all of the
cells that were in G2 at the start of the pulse had moved through this
G2 into mitosis within 30 min. These data not only clearly
demonstrate the presence of a G2 phase shortly after the MBT, but
also allow us to estimate the length of G2 in these cells to between 15
and 30 min.
G2 addition at the MBT is independent of zygotic transcription
The onset of zygotic transcription and the cell cycle lengthening
occur within a similar time window in zebraﬁsh and other organisms
(Edgar et al., 1986; Kane and Kimmel, 1993; Newport and Kirschner,
1982b), raising the possibility that transcription of new genes
contributes to the cell cycle remodeling occurring at MBT. The
previously described short G1 after MBT in the zebraﬁsh embryo is
dependent on zygotic transcription (Zamir et al., 1997), but that study
did not address the role of zygotic transcription in the cell cycle
lengthening that is observed between cycles 9 and 12. Given our
results detailing the previously overlooked importance of G2 addition
in lengthening, we decided to test whether zygotic transcription is
required for cell cycle lengthening at the MBT. We injected embryos
with 2 nl of a 0.2 mg/mL solution of the transcriptional inhibitor α-
amanitin, and measured cell cycle lengths before and during the MBT
by time-lapse microscopy. This concentration has previously been
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and in our hands, morphologically arrests embryos at the sphere stage
(not shown). In order to conﬁrm that the treatment prevents
activation of the zygotic genome, we used the H5 antibody, which is
speciﬁc for a phosphoepitope present only on actively elongating RNA
polymerase II (Ahn et al., 2004). Reactivity to H5 in zebraﬁsh embryos
is ﬁrst apparent at the 256-cell stage of control embryos (Fig. 2A), as
expected (Knaut et al., 2000). No H5 reactivity was detected in α-
amanitin injected embryos up to the 1 K stage (Fig. 2B).
We asked whether cell cycles in α-amanitin injected embryos
lengthen at the MBT in a similar manner to control embryos. We ﬁrst
injected embryos at the 1-cell stage with Alexa histone and measured
cell cycle lengths by time-lapse confocal microscopy (See Materials
and methods). Using this method, we found that control embryos
showed similar cell cycle kinetics to what was previously described
(Kane and Kimmel, 1993) with a slight increase in average cell cycle
length due to temperature (seeMaterials andmethods). Inα-amanitin
injected embryos, we observed robust lengthening that was within
the normal range observed in these time-lapse movies and not
statistically different from control embryos (pN0.05; Figs. 2C, D). This
suggests that transcription is not required for cell cycle lengthening,
and further suggests that the previously described G1 introduction,
which is dependent on zygotic transcription, is not required for large-
scale lengthening in the deep cells.
We then determinedwhether the G2 introduced at theMBT (Fig.1)
is independent of zygotic transcription, by performing BrdU-mitotic
trapping experiments at sphere stage in embryos injected with 2 nL of
0.2 mg/mL α-amanitin. The absence of BrdU-labeled mitotic ﬁgures in
both treated and untreated embryos after a 15-minute pulse (Fig. 2E)
indicated the presence of a transcription-independent gap phase, in
addition to the previously described transcription-independent S-
phase lengthening. As it was previously shown that the post-MBT G1
phase depends on new transcription (Zamir et al., 1997), the
transcription-independence of the gap phase we demonstrate here
strengthens our conclusion that this is a G2 phase that is added during
the MBT, and that G2 addition contributes to cell cycle lengthening in
the deep cells.
Elevated Cdc25a activity prevents cell cycle lengthening at the MBT
As Cdc25 destruction or inhibition occurs at the MBT in both
Drosophila (Edgar and Datar, 1996) and Xenopus embryos (Uto et al.,
2004), we wanted to determine whether elevation of zebraﬁsh Cdc25
activity could prevent cell cycle lengthening. We previously showed
that the zebraﬁsh genome has two cdc25 genes, cdc25a and cdc25d,
and that mRNA levels remain stable during and after the MBT (Dalle
Nogare et al., 2007). To directly test whether limitation of Cdc25
activity is required for cell cycle lengthening and asynchrony, we
provided excess Cdc25 activity by injection of mRNA for either cdc25a
or cdc25d into cleavage-staged blastomeres and measured the effects
on cell cycle length before, during and after the MBT. In order to
reduce experimental variation resulting from ﬂuctuations in tem-
perature or the effect of Histone injections, we injected cdc25 mRNA
into one blastomere at the 8-cell stage, and compared cell cycle
lengths between injected and uninjected lineages in the same
embryos (see Materials and methods). We ﬁrst conﬁrmed that
injection of 1 nl of liquid containing 50 pg (Supplemental Fig. S3) or
100 pg mRNA (not shown) did not alter cell cycle kinetics by injection
of egfp mRNA in a similar manner.
We next tested the ability of elevated Cdc25a or Cdc25d to override
cell cycle lengthening at the MBT. Injection of as little as 25 pg of
cdc25a abolished cell cycle lengthening at the MBT, ﬁrst visible in a
statistically signiﬁcant difference in average cell cycle length at cycle
10 (asterisks and brackets in Figs. 3A, B). Furthermore, cell cycles in
cdc25a-injected cells remained relatively synchronous compared to
uninjected control cells. Interestingly, we did not observe signiﬁcantshortening of the pre-MBT cell cycles in embryos injected with cdc25a
mRNA. This was also true when 50 pg (Figs. 3D, E) or 100 pg (Figs. 3G,
H) of cdc25amRNAwas injected. Thus, it is unlikely that this effect is a
function of protein accumulation to a threshold level only at the MBT,
but rather suggests that Cdc25a activity is not limiting for cell cycle
length prior to the MBT.
In no case did we observe a signiﬁcant shortening of the cell cycle
at MBT when up to 50 pg of cdc25d mRNA was injected (Figs. 3J, K).
These ﬁndings are consistent with our previous results indicating
appreciable differences in activity between Cdc25a and Cdc25d (Dalle
Nogare et al., 2007).
Cell cycle lengthening requires phosphoinhibition of Cdk1, but not Cdk2
Studies using mammalian cells indicate that Cdc25 activity is
required both at the G1-S transition, for activation of Cdk2, and the
G2-M transition for activation of Cdk1 (reviewed in Boutros et al.,
2006). Therefore, the above results do not address whether cell cycle
lengthening is accomplished by addition of a G1 or a G2 phase. To
determine the relevant target of Cdc25a activity at the zebaﬁsh MBT,
we used the assay described above to ask whether the constitutively
active form of Cdk1 or Cdk2 could prevent cell cycle lengthening and
desynchronization. Both Cdk1 and Cdk2 contain tyrosine and
threonine residues (T14A/Y15F) that are subject to inhibitory
phosphorylation. In both cases, mutations that change these residues
to alanine and phenylalanine preclude phosphoinhibition by Wee
kinases and therefore result in constitutive activity in the presence of
their respective cyclin co-factors (Perry and Kornbluth, 2007).
Injection of mRNA encoding cdk1AF (Figs. 4A, B), but not cdk2AF
(Figs. 4C, D) was sufﬁcient to bypass cell cycle lengthening at the MBT.
This suggests that the critical target of inhibitory phosphorylation at
the MBT is Cdk1 and not Cdk2, and that dephosphorylation of Cdk1 is
rate limiting for cell cycle progression during the MBT. Again, we did
not detect any signiﬁcant increase in the rate of pre-MBT cell cycles in
cdk1AF or cdk2AF injected clones. We found that increasing the
amount of wild-type Cdk1 present at theMBT does not affect cell cycle
dynamics in any detectable way (Figs. 4E, F), suggesting that removal
of phosphoinhibition of Cdk1 is responsible for the abrogation of cell
cycle lengthening at the MBTobserved when cdk1AF is overexpressed.
Bypassing cell cycle lengthening at the MBT results in
mitotic catastrophe
The above data demonstrate the requirement for Cdk1 inhibition
in cell cycle lengthening during the MBT. As S-phase lengthening
(Zamir et al., 1997) and G2 addition (Fig. 1) both occur during the MBT,
failure to lengthen the cell cycle could result frommaintenance of the
pre-MBT rate of DNA replication, or from G2 checkpoint bypass and
premature entry into mitosis. We favored the second possibility, as
cell cycle lengthening occurs normally when Cdk2 is constitutively
active.
To address this further, we observed the cdc25a- (Fig. 5) and
cdk1AF-injected (not shown) cells for evidence of mitotic catastrophe,
which would be expected if excess Cdk1 forced entry into mitosis
before S-phase is complete, but not if excess Cdk1 prevented S-phase
lengthening. At the end of the MBT (sphere stage), clones of injected
cells are inviable, showing nuclear abnormalities and other signs of
mitotic catastrophe, including incomplete separation and segregation
of chromosomes (Fig. 5B).
In time-lapse frames of cdc25a- and cdk1AF-injected clones, we
saw that mitoses proceeded at wild type rates (Figs. 3 and 4) and
without visible abnormalities up to cycle 10 (Fig. 5C). However, cells
progressed more rapidly through cycles 11 and 12 (Figs. 3 and 4) and
chromatin abnormalities were visible following cycle 12. By cycle 13,
more pronounced and widespread abnormalities in metaphase and
telophase were visible (red arrowheads, Fig. 5C).
Fig. 2. Cell cycle lengths and G2 determination in transcription-blocked embryos. (A, B) 1K-stage embryos that had been injected with water (A) or 0.4 ng α-amanitin (B) during
cleavage, stained for nuclei (blue) and the H5 antigen (red). (C, D) cell cycle lengths (C) and timing of divisions (D) measured by time-lapse microscopy. White bars and red line areα-
amanitin treated embryos, black bars and blue line are control embryos. (E) Mitotic pileup data from a 15-minute BrdU-nocodazole pulse showing the distribution of the four classes
of nuclei in untreated (black bars) and α-amanitin treated (checkered bars) injected embryos.
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Fig. 3. Time-lapse analysis of cell cycle lengthening in embryos injected with Alexaﬂuor-488 labeled Histone (green in C, F, I and L) and clonal injection of rhodamine dextran with
25 pg (A, B), 50 pg (D, E) or 100 pg (G, H) mRNA encoding 6MT-cdc25a or 50 pg 6MT-cdc25d (J, K). Open bars (A, D, G, J) or red lines (B, E, H, K) are injected cell lineages and ﬁlled bars
(A, D, G, J) or blue lines (B, E, H, K, E–H) are uninjected control cells. Panels C, F, I and L are frames from a time-lapse movie of an embryo injected with 25 pg 6MT-cdc25amRNA and
rhodamine-dextran. Panels C and L are initial and ﬁnal frames showing the rhodamine-dextran signal. White boxes in panels F and I indicate the approximate location of the injected
clone. Brackets and asterisks indicate that differences between injected and uninjected cell cycle lengths are statistically signiﬁcant (pb0.05).
137D.E. Dalle Nogare et al. / Developmental Biology 326 (2009) 131–142The above results are consistent with the hypothesis that mitotic
abnormalities result from failure to delay entry into M12–13.
However, we considered the alternative possibility that the timing
reﬂected a requirement for a critical concentration of Cdc25a protein
to accumulate from the injected mRNA. To test this possibility, we
repeated the experiment with 50 pg (not shown) and 100 pg cdc25a
(Supplemental Fig. S4) mRNA. In both cases, catastrophic mitoses
were observed only at M12, and no statistically signiﬁcant differences
in cell cycle length before cycle 10 were observed, relative to
uninjected blastomeres (Supplemental Fig. S4). We suggest this is afunction of progressive lengthening of S-phase occurring in cells
where the division cycle is held to pre-MBT length, by experimental
elevation of Cdc25/Cdk1 activity, causing premature entry into
mitosis.
Overexpression of cdc25 prevents G2 introduction at the MBT
To conﬁrm that the observed G2 phase introduction requires
phosphoinhibition of Cdk1, and that overexpression of Cdc25a and
Cdk1AF abrogates this G2 phase, we repeated the mitotic pile up
Fig. 4. Time-lapse analysis of cell cycle lengthening in embryos injected with 50 pg mRNA encoding cdk1AF (A, B) cdk2AF (C,D) or cdk1 (E,F). Open bars (A,C, E) or red lines (B, D, F) are
injected cell lineages and ﬁlled bars (A,C, E) or blue lines (B, D, F) are uninjected control cells. Brackets and asterisks indicate that differences between injected and uninjected cell
cycle lengths are statistically signiﬁcant (pb0.05).
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with 50 pg cdc25a mRNA into a single blastomere at the 8-cell stage,
performed the 15-minute BrdU/nocodazole incubations as described
and quantitated the number of BrdU-labeled mitotic ﬁgures. We
previously established that post-MBTembryos, inwhichmost cells are
in cycles 13 and 14, do not accumulate BrdU-labeled mitotic cells after
a 15-minute pulse, indicating that at least 15 min elapsed between the
end of S-phase and entry into mitosis (Fig. 1). Here, we performed the
pileup assay in cycle 12, due to the abnormal M13 that results fromcdc25a overexpression (Fig. 5). To control for variation between
embryos, we compared the number of BrdU-labeled mitotic ﬁgures
between the cdc25a- or egfp-injected cells and the uninjected cells
from the same embryos. In cycle 12, we do detect somemitotic ﬁgures
that are BrdU-labeled in uninjected or control injected cells after a 15-
minute pulse (red arrowheads in Figs. 6A, B; Table 1). Presumably this
is because the cell cycle as a whole, and potentially the G2 phase, is
shorter at this time than at sphere stage. Lineages injected with egfp
mRNA showed only a 1.46-fold increase in the number of BrdU-
Fig. 5. Cdc25a misexpression and DNA morphology in pre- and post-MBT clones. Embryos injected with 25 pg of mRNA encoding 6MT-cdc25a into single blastomeres at the 8-cell
stage and then processed for anti-Myc immunoﬂuorescence (red) and counterstained with Hoechst 33342 (green). Panels A and B show a pre-MBT (128-cells) and post-MBT (sphere)
embryo, respectively. Panel C shows time-lapse frames documentingmitotic divisions from cycle 7 through cycle 13, for a single cell lineage in a clone injectedwith 25 pg 6MT-cdc25a
mRNA. Red arrowheads show small chromatin bridges observed at the 1K + 1 division. I = interphase; P/M = pro-metaphase/metaphase; A/T = anaphase/telophase.
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contrast, cdc25a-injected cells showed a 12.8-fold increase in BrdU-
labeled mitotic ﬁgures relative to uninjected lineages in the sameFig. 6. BrdUmitotic pileup in clones injected with 50 pg egfpmRNA (A–C) or 50 pg 6MT-cdc25
(C, F) then exposed to BrdU and nocodazole at 28 °C for 15 min. Embryos were then stai
counterstained with TO-PRO 3 (white in A, D; blue in C, F). Red arrowheads in panels A, B, D
negative mitotic ﬁgures.pool of embryos (Figs. 6D–F; Table 1). We conclude therefore that
cdc25a overexpression forces entry into mitosis from S-phase, with
little or no G2.amRNA (D–F). Embryos were injected with mRNAmixed with 70 K rhodamine dextran
ned with anti-BrdU monoclonal antibody (white in B, E; green, C, F) and nuclei were
and E indicate BrdU-positive mitotic ﬁgures, and white arrowheads in A indicate BrdU-
Table 1





% BrdU+ ﬁgures in
injected/uninjected cells
cdc25a-injected embryos (n=4)
cdc25a clone 56 36 (64%) 12.8
Uninjected cells 182 10 (5%)
egfp-injected embryos (n=4)
egfp clone 32 6 (19%) 1.46
Uninjected cells 159 20 (13%)
All mitotic cells were identiﬁed by condensation of nuclei in TOPRO stained embryos.
For each set of embryos (cdc25a-injected vs. egfp-injected), the total number of BrdU+
labeled mitotic ﬁgures was determined for injected and uninjected cells and pooled
within each group. The ratio of BrdU labeled (BrdU+) mitotic ﬁgures in injected vs.
uninjected cells was calculated.
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As the activation of zygotic transcription is occurring at the time of
cell cycle lengthening, we wanted to determine whether bypassing
cell cycle lengthening at the MBT also resulted in a failure to initiate
zygotic transcription. We examined initiation of zygotic transcription
in clones of cells injected with cdc25a mRNA. In order to detect
activation of the zygotic genomewith high spatial resolution, we used
the H5 antibody, which recognizes actively elongating RNAPol II (Ahn
et al., 2004). In Fig. 7, we show that embryos at the 1 K-cell stage that
had been asymmetrically injected at the 8-cell stage with mRNA
encoding cdc25a in rhodamine dextran solution have H5 reactivity in
both injected and uninjected lineages. While we can conclude that
cell cycle lengthening is not required to induce the initiation of
zygotic transcription, this experiment does not address whetherFig. 7. Zygotic genome activation in a cell clone injectedwith 50 pg 6MT-cdc25amRNA in 70K
and stained with anti-H5 monoclonal antibody (white in C; red in D) and Hoechst 33342 (wh
outlined with a dashed line in B–D.transcript elongation and accumulation require cell cycle lengthen-
ing. In Drosophila grapes mutant embryos, in which cell cycle
lengthening and checkpoint addition are abrogated, several early
transcripts can be detected, but in lower amounts and in abnormal
patterns (Sibon et al, 1997). We therefore consider it very unlikely
that signiﬁcant transcript elongation and accumulation could occur in
cell cycles abbreviated by cdc25a overexpression, however it was not
possible to test this as cdc25a-injected clones have severe nuclear
abnormalities by cycle 12. Our data conﬁrm, however, that initiation
of zygotic transcription and cell cycle remodeling are independently
controlled events.
Discussion
We have presented the ﬁrst high-resolution analysis of cell cycle
diversiﬁcation by phosphoregulation of Cdk1 at the MBT in a
vertebrate embryo. We have demonstrated that phosphoinhibition
of Cdk1 is required for cell cycle lengthening at the MBT and that a G2
is introduced during the MBT. This G2 is neither dependent on zygotic
transcription nor required for transcription initiation, but can be
bypassed by experimental elevation of Cdc25a and Cdk1 activity. We
have demonstrated that G2 introduction at the MBT is necessary for
preventing premature mitosis as S-phase lengthens due to the
increasing nueclocytoplasmic ratio. Our data point to similar mechan-
isms governing the MBT in diverse species.
Reduction of Cdk1 activity couples DNA replication to a
cytoplasmic oscillator
Numerous observations suggest that DNA replication and mitosis
are not explicitly coupled during cleavage, butmust become so atMBT.-Rhodamine Dextran (A) at the 8-cell stage (A–D). Embryoswere ﬁxed in cycle 11 (1K+1)
ite in B; green in D). D: Overlay of panels A–C. The Rhodamine dextran-positive clone is
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activity has been observed in Xenopus embryos and artiﬁcially
activated unfertilized eggs (Hara et al., 1980; Gerhart et al., 1984). A
similar oscillator has been proposed in Drosophila (Edgar et al., 1994)
and in unfertilized and enucleated zebraﬁsh embryos (Kane and
Kimmel, 1993). At the MBT the oscillator is superceded by constraints
imposed on cell cycle length by the nucleocytoplasmic ratio.
We havemade two observations that are relevant to the nature and
the regulation of the oscillator, which in our assays has a period
ranging from 18 to 25 min. First, expression of even very high levels of
cdc25a and cdk1AF mRNA do not decrease cell cycle length or induce
mitosis before completion of DNA replication prior to cycle 10,
suggesting that the oscillator is not limited by the availability of
Cdc25a or phospho-Cdk1 during this time. Second, in the continued
presence of high levels of Cdc25 or Cdk1AF, the 18–25-minute
oscillator is maintained throughout the MBT, even though S-phase is
lengthening. The result of this is mitotic catastrophe, when cells enter
mitosis before the completion of DNA replication. Thus, limitation of
Cdk1 activity lengthens the cell cycle in two ways, not only allowing
the addition of a G2 phase, which provides a temporal gap between S-
phase completion and initiation of mitosis, but also in ensuring that S-
phase lengthening can feed back on the oscillator to prevent entry into
mitosis before S-phase is complete.
Our data suggest that limitation of this oscillator requires
phospho-inhibition of Cdk1, as expression of high levels of unpho-
sphorylatable Cdk1 or overexpression of Cdc25a after cycle 11
maintains the pre-MBT cell cycle length. We have also shown by the
rapid accumulation of BrdU-positive mitotic ﬁgures that this results in
entry into mitosis directly from S-phase. This early entry into mitosis
in embryos overexpressing cdc25a or cdk1AF suggests that phospho-
inhibition of Cdk1 is required for an S-phase completion checkpoint at
the MBT, and may also underlie the introduction of a G2 at the MBT.
Similar observations were made in Drosophila embryos from wee-
deﬁcient mothers (Stumpff et al., 2004) inwhich cycles 11–13 failed to
lengthen and which displayed spindle abnormalities and chromo-
some segregation defects indicative of incomplete DNA replication.
Thus, failure to decrease Cdk1 activity at the MBT results in
maintenance of the pre-MBT interphase length, even though it is no
longer sufﬁcient for complete DNA replication. Our results are
consistent with the proposal that the presence of a large number of
replication forks or other signs of under-replicated DNA, which
increase with the nucleocytoplasmic ratio, triggers the activation of
checkpoints that attenuate Cdc25 and Cdk1 activity to slow the
cytoplasmic oscillator.
Interestingly, we previously reported that ectopic overexpression
of cdc25awell after the MBT by the zygotically active hsp70 promoter
increases the mitotic index of deep cells (Dalle Nogare et al., 2007). In
these experiments, we did not observe catastrophic mitoses or any
evidence of entry into mitosis directly from S-phase. These observa-
tions suggest that once the oscillator has been coupled to DNA
replication at the MBT, elevated Cdc25 is not sufﬁcient to overcome
the S-phase exit checkpoint, but most likely acts only by shortening
the G2 phase.
G2 acquisition is a common event at the MBT
Our data do not address the occurrence or signiﬁcance of addition
of a G1 phase to the cell cycle at MBT, as has been previously observed
in zebraﬁsh embryo (Zamir et al., 1997). In those experiments, b7% of
cells in cycle 12 were found to have a 2 N DNA content, indicating
either a very short G1 in many cells, or a more signiﬁcant G1 in a small
population of cells. However, we demonstrate that G2 acquisition is
transcription-independent and essential for the DNA replication
checkpoint. Therefore we propose that G2 acquisition, rather than
G1 acquisition, underlies the cell cycle remodeling at theMBT formost
cells in the embryo. This model is consistent with those from otherspecies where the MBT has been extensively studied. In Drosophila
embryos, the post-blastoderm cell cycles of the epidermis proceed
without a G1 phase, which is ﬁnally established as a terminal G1 phase
until larval endocycles begin (Foe and Alberts, 1983; Edgar and
O'Farrell, 1989; Knoblich et al., 1994; de Nooij et al., 1996; Lane et al.,
1996). In Xenopus, it is also likely that acquisition of a G2 phase occurs
after initial lengthening of S and M phases and precedes G1
acquisition at least in most cells (Iwao et al., 2005).
Kane et al. have described three mitotic domains that are
established immediately following the MBT (Kane et al., 1992).
These include the extraembryonic lineages of the enveloping layer
(EVL) and yolk syncitial layer (YSL), as well as the deep cells, which
give rise to all embryonic tissue. In our experiments, we have
speciﬁcally followed lineages that contribute to the deep cells,
which continue to proliferate relatively rapidly through gastrula
stages, with average cell cycle lengths progressively increasing. The
YSL nuclear cycles remain rapid and synchronous through cycle 13,
whereas the EVL cell cycles lengthen considerably more than the deep
cells. It is highly likely, therefore, that remodeling of the YSL and EVL
cycles requires differentmechanisms than in the deep cells. Given that
the EVL cell cycles become very long after MBT, these cells have been
proposed as the candidates for G1-containing cell cycles (Zamir et al.,
1997), and examination of their post-MBT behavior will be of interest.
We have not addressed the mechanism by which phospho-
inhibited Cdk1 increases, however, our results do indicate that the
presence of high levels of wild type Cdc25a protein are sufﬁcient to
overcome any negative regulatory mechanisms. Multiple, redundant
mechanisms have been implicated in both Drosophila and Xenopus
embryos to ensure Cdk1 inactivation at the MBT. The degradation of
maternal string and twine mRNA (Edgar and Datar, 1996), a well as
Chk1-dependent degradation of Cdc25 proteins (Sibon et al., 1997)
ensures a complete and prolonged G2 arrest after S14 in Drosophila. In
Xenopus, Cdc25A mRNA is not degraded or depleted until gastrula
stages (Petrus et al., 2004) and Cdc25A protein degradation is not
essential for the MBT (Shimuta et al., 2002). However, Chk1 activity at
the MBT has been shown to be required for both the phosphorylation-
dependent attenuation of Cdc25A activity (Uto et al., 2004), and the
stabilization of Wee1 (Petrus et al., 2004). In both organisms,
interference with Chk1 activation abrogates the replication check-
point (Carter and Sible, 2003; Sibon et al., 2000; Takada et al., 2007).
Given the similarities between zebraﬁsh, Xenopus and DrosophilaMBT
revealed by our work, we propose that some components of these
multiple, redundant mechanisms operating in other organisms also
promote Cdk1 inactivation at the zebraﬁsh MBT.
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